type here...

Pharmaceuticals

When Medical Experiments Serve the Business Needs of Pharmaceutical Firms Instead of Science

Guy Rolnik
The first part of a two-part interview with Daniel Goldstein, MD, an oncologist who also studies the influence of business interests on healthcare—from treating patients...

Why is Medical Marijuana Still Not Accepted in All 50 States? Ask George Stigler

Asher Schechter
A new working paper by University of Georgia researchers shows that medical marijuana leads to sharp drops in the number of prescriptions for...
12Page 2 of 2

LATEST NEWS

The publication of the Stigler Center at The University of Chicago Booth School of Business

ProMarket is dedicated to discussing how competition tends to be subverted by special interests. The posts represent the opinions of their writers, not necessarily those of the University of Chicago, the Booth School of Business, or its faculty. For more information, please visit ProMarket Policy.